Skip to main content

Advertisement

SpringerLink
Log in

Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?

  • Clinical Trial Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kappos L, Radue EW, O’Connor P, et al.: A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010, 362:387–401.

    Article  CAS  PubMed  Google Scholar 

  2. Cohen JA, Barkhof F, Comi G, et al.: Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010, 362:402–415.

    Article  CAS  PubMed  Google Scholar 

  3. Giovannoni G, Comi G, Cook S, et al.: A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 2010, 362:416–426.

    Article  CAS  PubMed  Google Scholar 

  4. Chun J, Hartung HP: Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 2010, 33:91–101.

    Article  CAS  PubMed  Google Scholar 

  5. Comi G, O’Connor P, Montalban X, et al.: Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. Mult Scler 2010, 16:197–207.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, UHS-42, Portland, OR, 97239, USA

    Vijayshree Yadav & Dennis Bourdette

Authors
  1. Vijayshree Yadav
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dennis Bourdette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vijayshree Yadav.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yadav, V., Bourdette, D. Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?. Curr Neurol Neurosci Rep 10, 333–335 (2010). https://doi.org/10.1007/s11910-010-0126-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-010-0126-2

Keywords

Search

Navigation